
$26 Billion Oxycontin Settlement Will Fund Drug Treatment Services in 14 States
14 states have agreed to a $26 billion settlement with

14 states have agreed to a $26 billion settlement with
The recent $26 billion settlement reached with Purdue Pharma over their role in the opioid crisis will have a significant impact on drug treatment services in 14 states, including New York. This landmark settlement will provide much-needed funding for programs and resources to help those struggling with addiction to Oxycontin and other opioids.
Consultants like AZZLY are crucial players in helping organizations navigate the complex landscape of drug treatment services. With their expertise and support, providers in states like New York can maximize the impact of the settlement funds, ensuring that those in need receive the help they deserve.
The recent $26 billion settlement reached with Purdue Pharma over their role in the opioid crisis will have a significant impact on drug treatment services in 14 states, including New York. This landmark settlement will provide much-needed funding for programs and resources to help those struggling with addiction to Oxycontin and other opioids.
Consultants like AZZLY are crucial players in helping organizations navigate the complex landscape of drug treatment services. With their expertise and support, providers in states like New York can maximize the impact of the settlement funds, ensuring that those in need receive the help they deserve.